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A cDNA was isolated from  human  brain  that  encodes 
an  amino  acid sequence 34-399’0 identical to previously 
published  glutamate  transporter sequences. Injection of 
RNA transcribed from this cDNA into Xenopus oocytes 
resulted in expression of a  transport activity with the 
properties of the neutral  amino acid uptake  system ASC. 
Superfusion of alanine, serine, and cysteine evoked so- 
dium-dependent inward currents in voltage-clamped 
oocytes expressing the transporter.  These  currents  were 
dose-dependent, stereospecific, and  saturable,  with K ,  
values ranging from 29 to 88 p. Northern  blot analyses 
revealed ubiquitous expression of this gene, termed 
ASCT1, consistent with the general metabolic role as- 
cribed to system ASC. 
The ce l lu la r   up take  of amino  acids  is mediated by multiple 
independent   t ranspor t  systems distinguished primarily  by sub- 
strate preference and by ionic requirements. In mammal i an  
cells, neutral amino acids are transported predominant ly  by 
two  sodium-dependent   systems termed ASC  (for alanine, ser- 
ine,  and cysteine  preferring) and A (for alanine preferring) (1- 
3). N-Methylated  amino  acids  and the related compound 
MAIB’ are not  substrates for system ASC, a property that 
allows it t o  be operationally distinguished from  system A (4). 
ASC-mediated t r anspor t  is the major  component  of neut ra l  
amino   ac id  uptake in a wide  variety of  cell  types. 
A number of the classic   amino  acid  t ransport   systems  have 
now been cloned and demonst ra ted   by  structural homologies  to 
be members  of dist inct  gene families. These include system Gly 
(5-7), the neutral amino  ac id   t ranspor t  system A (81, the basic 
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amino  acid transport sys tem y+ (9, lo), and  the acidic  amino 
ac id   t ranspor t  system X- (referred  to here as glutamate trans- 
porters). Glutamate transporter subtypes were recently iso- 
lated from rat brain (11, 12) and rabbit intestine (13), and 
demons t r a t ed   t o  be structurally related members of a trans- 
por te r  gene family that also  exhibit   regions of homology with 
glt-P (14) and dctA  (15),  two  bacterial nutrient uptake systems. 
We repor t  the cloning,  expression, and functional  characteriza- 
t ion of a human gene product that is s t ruc tura l ly  related t o  the 
glutamate t ranspor te r  gene family and whose  properties  cor- 
respond  to  the neutral amino  ac id   up take   sys tem ASC. 
EXPERIMENTAL PROCEDURES 
cDNA Cloning and Sequencing-The amino acid sequence of 
GLASTl (11) was  obtained  from the Swiss  Protein  Database  (accession 
no. P24942).  A  synthetic oligonucleotide complementary  to the  amino 
acid sequence ATINMDGTALYEALAAIFIAQ (residues  395-415 of 
GLAST1) was  synthesized  because  the  conservation of portions of this 
sequence in  the  Escherichia coli glutamate  carrier  protein  glt-P  (14) 
suggested an  important  and conserved  structural  motif.  This oligonu- 
cleotide  sequence  (5‘ CTG (A/G)GC (A/G)AT GAA (A/G)AT GGC AGC 
CAG GGC (C/T)TC ATA CAG GGC TGT GCC (A/G)TC CAT GTT (A/ 
G)AT GGT (A/G)GC 3’) is 128-fold degenerate  and  utilizes  human codon 
preferences. Human motor  cortex  RNAisolated by the  method of Chom- 
czynski and Sacchi (16) and poly(A+) enriched by oligo(dT)-cellulose 
chromatography  were  used to  prepare  a cDNA library. Mixed oligo(dT) 
and  random-primed cDNA was  synthesized  using the  Superscript 
Choice System (Life Technologies Inc.)  and  ligated  into AZAPII (Strat- 
agene,  La  Jolla, CA). The oligonucleotide was  32P-labeled for screening 
this  human cortex  library.  Conditions  for  hybridization  and  wash  were: 
0.5 M Na2HP0,,  pH 7.15, 7% SDS for hybridization a t  50 “C, and  wash 
at  60 “C in  2 x SSPE, 1% SDS.  The  plasmid pASCT1, obtained by in vivo 
excision (Stratagene) of a hybridizing AZAPII clone, contained  a 2.7-kbp 
cDNA insert  that  was equenced on both strands by the dideoxy chain 
termination  method  using  Sequenase 2.0 (U. S. Biochemical Corp.)  and 
synthetic oligonucleotide primers (Oligos Etc.). 
Expression of ASCTl  in Oocytes-The coding sequence of pASCTl 
was  isolated  with  unique  flanking  restriction  sites by the polymerase 
chain  reaction  using  synthetic oligonucleotide primers.  Plasmid pOTV- 
ASCTl  contains  this DNA sequence subcloned into  the  polylinker of an 
oocyte transcription  vector that  utilizes Xenopus 6-globin 5’- and  3’- 
untranslated  regions  derived from pSP64T  (17)  to  enhance  expression 
levels in oocytes. Synthetic RNA was  transcribed  in  vitro (18) and  in- 
jected  into  defolliculated  stage V-VI Xenopus oocytes. Transport  was 
assayed  as  described  previously by measuring  uptake of c3H1alanine, 
r3H1serine, or [35Slcysteine  (all  radiolabeled  compounds from Du Pont- 
New England  Nuclear)  and by two-electrode voltage-clamp  recording 
(18). Briefly, oocytes were  voltage-clamped at  -60 mV and  continuously 
superfused  with  a  buffer  (ND-96)  consisting of 96 mM NaC1, 2 mM KC1, 
1.8 mM CaCl,, 1 mM MgC12, and  5 mM HEPES pH 7.5. For  transport 
measurements,  this  solution  was  changed to the  indicated  concentra- 
tion of amino acid in ND-96. Current (1) as a function of substrate 
concentration ([SI) was  fitted by least  squares  to I = I,,;[S]/(K, + [SI), 
where lmax is  the  maximal  current  and K,,, is  the  transport  constant. 
Values of K, and I,,, were determined by fitting the results from 
individual oocytes in  which five or  more  different  concentrations  were 
applied.  Data  were  averaged from all oocytes tested  and  are  expressed 
as  mean * S.E. 
Northern Blot Analysis-The human  tissue  Northern  blot  was ob- 
tained  from  Clontech  Laboratories,  and  human  brain  region RNAs were 
prepared (16) from tissue provided by the Oregon Brain Repository. 
RNAs were size-fractionated on denaturing formaldehyde gels and 
transferred to a nylon membrane. The 1.7-kbp coding sequence of 
ASCTl  was  radiolabeled  with  a-[32PldCTP  (Du  Pont-New  England  Nu- 
clear) by the  random  priming  method  (Boehringer  Mannheim).  Filters 
were  hybridized  overnight at 42 “C with  this cDNA probe (lo6 cpdml )  
in 5 x SSPE  (20 x SSPE = 3 M NaCl, 0.2 M NaH,PO,, 0.02 M Na,EDTA, 
pH 7.4). 50% formamide,  7.5 x Denhardt’s  solution, 2% SDS,  and  100 
pg/ml denatured  salmon  sperm DNA. Autoradiography  was  performed 
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after two 30-min room temperature  washes  in 2 x SSPE, 0.1% SDS and 
two 20-min washes at  50 "C in 0.1 x SSPE, 0.1% SDS. Filters were 
subsequently  reprobed  with  a  radiolabeled  human  p-actin probe (Clon- 
tech  Laboratories,  Palo  Alto). 
RESULTS 
A novel cDNA clone was  isolated during  the course of screen- 
ing a human motor cortex cDNA library for sequences related 
to  rat (11) and E. coli (14)  glutamate  transporters. Nucleotide 
sequence analysis of this clone predicted an open reading  frame 
of 532 amino  acids and corresponding to  a  protein of -56 kDa, 
flanked by -180 base  pairs of 5'-untranslated sequence and 
-0.9 kbp of 3"untranslated sequence. The  start of the coding 
sequence  was defined by the  first ATG downstream of an  in- 
frame stop codon, and  the  surrounding sequences ( G C C E G )  
conform to a  consensus translation  initiation  site (19).  A  frag- 
ment of this cDNA sequence (-nucleotides 1156-1492) was 
among the randomly  selected clones sequenced by Adams et al. 
(20) and referred to as EST02446. We term this sequence 
ASCTl because of the functional properties of the encoded 
transport activity. 
The ASCTl amino acid sequence shown in Fig. 1 exhibits 
remarkable  similarity to those reported for glutamate  trans- 
porter subtypes. Amino acid identities among these sequences 
have been  highlighted to  illustrate  the conservation of gluta- 
mate  transporter  structural motifs within  the ASCTl sequence. 
ASCTl  has  39,34,  and 39%  sequence identity  with  rat GLASTl 
(ll), rat  GLTl  (12),  and  rabbit EAACl (13), respectively. This 
sequence identity  is comparable  with the  identity  seen between 
the  subtypes themselves. All sequences  exhibit unrelated NH2 
and COOH termini,  and diversity in a putative  extracellular 
transporter domain containing conserved potential N-linked 
glycosylation sites (Fig. 1). Another  notable difference resides 
in a region highly conserved in  the  glutamate  transporters  (see 
the ASCTl  sequence  IFQC, residues 384-387) and may be re- 
lated to the  determination of substrate specificity. The  absence 
of a signal peptide sequence suggests  the amino terminus  is 
intracellular,  but  other  aspects of the  transmembrane topology 
of this  transporter family are  currently controversial  because 
many of the hydrophobic regions  predicted by sequence  hydrop- 
athy analyses are more consistent with P-sheets than with 
a-helices. Six membrane-spanning regions are predicted in  the 
NH2-terminal portion of ASCT1, consistent  with  domains pro- 
posed for the  glutamate  transporters (11-13), and as many  as 
four transmembrane regions may be present in the COOH- 
terminal portion. 
The sequence similarity of ASCTl with known glutamate 
transporters suggested that this protein might function to 
transport  glutamate or other  amino acids. We have previously 
utilized  expression in oocytes and voltage clamp recording to 
characterize  system  y+ (101, and  others  have utilized similar 
assays  to  characterize  the activity of glutamate  transporters 
(13).  Superfusion of ASCTl RNA-injected oocytes voltage- 
clamped at -60 mV with the  amino acids alanine,  serine,  and 
cysteine produced inward  currents  that were absent in unin- 
jected controls (Fig. 2 A ) .  These uptake currents were dose- 
dependent  and  saturable (Fig.  2,  B and C, and Table I). Thre- 
onine and valine  also elicited currents,  but with lower 
affinities. Lysine or glutamate did not elicit detectable re- 
sponses (Fig. 2 A ) ,  and  the  system A-specific substrate MAIB 
neither evoked a detectable current nor inhibited the  current 
elicited by alanine. N-Methylalanine at 1 mM did not produce a 
detectable current nor did proline, glycine, glutamine,  aspara- 
gine, methionine, arginine, or leucine (data not shown). The 
rate of radiolabeled amino acid uptake (in pmol/min.oocyte, 
determined at  100 p ~ )  in ASCT1-expressing oocytes was 18.0 f 
2.0 for alanine, 20.1 2 5.1 for serine,  and 19.2 2 5.9 for cysteine, 
while the comparable  values in uninjected controls were 0.6 2 
0.1, 0.4 f 0.1, and 1.0 * 0.3, respectively ( n  = 5).  Uptake of 100 
PM L3H1alanine was  unaffected by the addition of 10 mM MAIB 
(107% of control; n = 2). 
ASCT1-mediated transport was  also  examined for ster- 
eospecificity and ion sensitivity. The  current induced by o-ala- 
nine a t  1 mM was only 12 f 3% of the  current obtained  with 1 
mM L-alanine ( n  = 3). The inward current elicited by 1 mM 
L-alanine superfusion  was not  seen when  Tris was substituted 
for Na+ (Fig. 2 A ) .  The  current induced by 1 mM alanine was  also 
reduced 61 4% ( n  = 4) when extracellular K+ was increased 
from 2 to 20 mM. 
The  expression of ASCTl mRNA was  analyzed by Northern 
blotting of  RNAs from various human  tissues. Two prominent 
RNA species 5.1 and 4.0 kb  in  length,  and a smaller hybridizing 
band corresponding to 2.4 kb,  were  detectable in  all  lanes  (Fig. 
3A). The  nature of these multiple RNA species is  unclear  but 
may reflect differential RNA processing. ASCTl RNA appears 
to be most abundantly expressed in brain, muscle, and pan- 
creas  but was  detectable in  all  tissues examined. The expres- 
sion of ASCTl in various regions of human brain was also 
examined and found to be uniformly distributed (Fig. 3B 1. 
FIG. 1. ASCTl is structurally re- 
lated  to mammalian glutamate  trans- 
porters. The  deduced  amino acid se- 
quence of human  ASCTl  is  shown  aligned 
with the sequences  reported for the glu- 
tamate  transporter  subtypes  GLASTl 
(111, GLTl (121, and EAACl (13). Gaps 
(indicated by dashes) were  introduced 
into the protein sequences to facilitate 
their  alignment.  Positions  where at least 
three of the four  protein  sequences  have 
identical amino acid residues are indi- 
cated by white on black lettering. Poten- 
tial  N-linked glycosylation sites (N-X-Sfl') 
are outlined  within boxes. 
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FIG. 2. Inward currents evoked by amino acids in voltage- 
clamped  ASCT1-expressing oocytes. A, amino acids (1 mM) were 
superfused for the duration indicated by the bar. Sodium-dependent 
currents were induced by  L-alanine,  1.-serine, and L-cysteine in ASCT1- 
expressing oocytes but not in uninjected controls. B ,  currents elicited 
were dose-dependent and saturable. C,  concentration response data 
were fitted to  the Michaelis-Menten equation to obtain the kinetic pa- 
rameters  listed in Table I. 
TARLF. I 
Kinetic  parameters of amino  acid  substrates 
Amino acid K", I,.." 
Ita1 
L-Alanine 71 14 (1.0) 
L-Serine 88 2 11 1.2 f 0.08 
L-Cysteine 29 2 6 1.0 = 0.04 
!.-Threonine 137 = 19 1.4  0.03 
L-Valine 390 f 8 0.6 f 0.11 
" Maximum currents obtained with each substrate were normalized 
to  the maximal current induced by alanine  in  the  same oocyte ( n  = 3-5). 
2.4- 
1.4- 






FIG. 3. Expression of ASCTl  mRNA  in  human  tissues. A, North- 
e m  blot analysis  using  the radiolabeled coding sequence of ASCTl as a 
hybridization probe. Two pg of'polylA') RNA was loaded per lane. Lane 
1, heart; lane 2, brain; lane 3, placenta; lane 4,  lung; lane 5 ,  liver; lane 
6, skeletal muscle; lane 7, kidney; lane 8, pancreas. In the lower  panel, 
the same filter was reprobed with a human 8-actin cDNA. 8-Actin 
mRNA is approximately 2.0 kb in length, but in heart and skeletal 
muscle an abundant 1.7-kb actin mRNA species  also hybridizes. B,  20 
pg of total RNA  prepared  from human brain regions was analyzed as in 
A. Lane I ,  motor cortex; lane 2, frontal cortex; lane 3, hippocampus; lane 
4, basal ganglia; lane 5, cerebellum. Hybridization of this filter with the 
p-actin probe is shown in the hottom panel. 
DISCUSSION 
On the  basis of amino acid sequence homology, ASCTl  is a 
member of the  gene family recently defined by the cloning of 
mammalian  glutamate  transporter  subtypes (11-13). The pre- 
dicted ASCTl  amino acid sequence contains  many of the highly 
conserved structural  features of the GLAST1,  GLT1, and 
EAACl transporter  subtypes,  as depicted in Fig. 1. Moreover, 
ASCTl  also contains  the  heptapeptide sequence AA(W)FIAQ 
that  is found in  the bacterial  genes for a glutamatelaspartate 
carrier protein (14)  and a dicarboxylate carrier protein ( E ) ,   a s  
well as in the  mammalian sequences.  These structural  paral- 
lels  with acidic amino acid carrier proteins are  striking in view 
of the  marked difference ASCTl  has in substrate specificity. 
These findings demonstrate  that  the functional  diversity of this 
gene  family is broader than previously suspected. 
In  agreement  with previous studies of system ASC transport, 
ASCTl demonstrated a  broad specificity for neutral  amino ac- 
ids. Alanine, serine, cysteine, and threonine were the most 
effective substrates, and cysteine had the highest measured 
transport affinity (K, = 29 p~). ASCTl exhibited sodium de- 
pendence and stereospecificity for the L-enantiomer of alanine 
and did not  transport  N-methylalanine.  The system A-specific 
substrate MAIB was not a substrate for ASCT1, and  it did not 
inhibit  alanine  uptake.  These  are defining characteristics of 
system ASC (2, 3). Despite the  structural homology of ASCTl 
with glutamate  transporters  but  consistent with  system ASC, 
glutamate  and  aspartate were not effective substrates. As there 
have been reports  that system ASC does transport  glutamate 
with low affinity when the pH is reduced (21,22),  further  stud- 
ies will be required  to analyze this phenomenon. 
Although the  substrates of ASCTl and  the  glutamate  trans- 
porters differ, the  structural  similarities of these proteins  sug- 
gest  that  they  may function by similar mechanisms. Uptake of 
glutamate  is  an electrogenic process that  appears  to be coupled 
to  the  cotransport of  Na' and  the  countertransport of intracel- 
lular K' and of an additional  pH-changing  anion (23-25).  Con- 
sistent with the notion of a conserved ionic mechanism,  ASCTl- 
mediated transport  was found to be electrogenic and sensitive 
to elevated extracellular K+ as well as reduced extracellular 
Na'. System ASC has been suggested to be electroneutral (26), 
and K' sensitivity has not been reported.  Previous studies of 
system ASC have necessarily been conducted in cells with  mul- 
tiple partially overlapping transport activities. However, the 
overexpression of the cloned ASCTl  gene  product in Xenopus 
oocytes and  the utilization of voltage-clamp control allow direct 
demonstration of these properties. The  substrate specificity of 
ASCT1-mediated transport  argues  that  this cDNA clone en- 
codes the biochemically defined cellular uptake system ASC. 
ASCTl mRNA was found to be expressed  in  all human  tis- 
sues examined,  with the  highest levels detected in  brain, skel- 
etal muscle, and pancreas. The  abundant expression in  brain  is 
particularly  intriguing because cysteine, the  ASCTl  substrate 
with the  highest affinity, has been reported to have neurotoxic 
effects in  the  central nervous  system (27). Thus,  ASCTl  and  the 
glutamate  transporters may have  similar roles  in preventing 
the accumulation of endogenous neurotoxic amino acids. The 
molecular cloning of ASCTl will provide an  avenue  to explore 
further  the role of this  neutral  amino acid transport system  in 
neuronal  and cellular physiology. Moreover, the  structural sim- 
ilarity of ASCTl with glutamate  transporter  subtypes may  aid 
in the elucidation of structure/function relationships in this 
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